Recent Finacing
Recent Raise
Blade Therapeutics develops therapies that modify fibrotic disease pathobiology, leveraging target biology from Harry Dietz’s Johns Hopkins lab for lead molecule discovery and preclinical development in South San Francisco.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors